Matches in Wikidata for { <http://www.wikidata.org/entity/Q100496088> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- Q100496088 description "2020 nî lūn-bûn" @default.
- Q100496088 description "2020年の論文" @default.
- Q100496088 description "2020年学术文章" @default.
- Q100496088 description "2020年学术文章" @default.
- Q100496088 description "2020年学术文章" @default.
- Q100496088 description "2020年学术文章" @default.
- Q100496088 description "2020年学术文章" @default.
- Q100496088 description "2020年学术文章" @default.
- Q100496088 description "2020年學術文章" @default.
- Q100496088 description "2020年學術文章" @default.
- Q100496088 description "2020年學術文章" @default.
- Q100496088 description "2020年學術文章" @default.
- Q100496088 description "2020年學術文章" @default.
- Q100496088 description "2020년 논문" @default.
- Q100496088 description "article científic" @default.
- Q100496088 description "article scientific" @default.
- Q100496088 description "article scientifique" @default.
- Q100496088 description "articol științific" @default.
- Q100496088 description "articolo scientifico" @default.
- Q100496088 description "artigo científico" @default.
- Q100496088 description "artigo científico" @default.
- Q100496088 description "artigo científico" @default.
- Q100496088 description "artikel ilmiah" @default.
- Q100496088 description "artikull shkencor" @default.
- Q100496088 description "artikulong pang-agham" @default.
- Q100496088 description "artykuł naukowy" @default.
- Q100496088 description "artículo científico publicado en 2020" @default.
- Q100496088 description "artículu científicu" @default.
- Q100496088 description "bilimsel makale" @default.
- Q100496088 description "bài báo khoa học" @default.
- Q100496088 description "naučni članak" @default.
- Q100496088 description "scienca artikolo" @default.
- Q100496088 description "scientific article published on 08 October 2020" @default.
- Q100496088 description "scientific article published on 8 October 2020" @default.
- Q100496088 description "scientific article published on 8 October 2020" @default.
- Q100496088 description "teaduslik artikkel" @default.
- Q100496088 description "tieteellinen artikkeli" @default.
- Q100496088 description "tudományos cikk" @default.
- Q100496088 description "vedecký článok" @default.
- Q100496088 description "vetenskaplig artikel" @default.
- Q100496088 description "videnskabelig artikel udgivet 8. oktober 2020" @default.
- Q100496088 description "vitenskapelig artikkel" @default.
- Q100496088 description "vitskapeleg artikkel" @default.
- Q100496088 description "vědecký článek" @default.
- Q100496088 description "wetenschappelijk artikel" @default.
- Q100496088 description "wissenschaftlicher Artikel" @default.
- Q100496088 description "επιστημονικό άρθρο" @default.
- Q100496088 description "мақолаи илмӣ" @default.
- Q100496088 description "наукова стаття, опублікована в жовтні 2020" @default.
- Q100496088 description "научна статия" @default.
- Q100496088 description "научная статья" @default.
- Q100496088 description "научни чланак" @default.
- Q100496088 description "научни чланак" @default.
- Q100496088 description "מאמר מדעי" @default.
- Q100496088 description "مقالة علمية نشرت في 8 أكتوبر 2020" @default.
- Q100496088 description "৮ অক্টোবর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q100496088 description "บทความทางวิทยาศาสตร์" @default.
- Q100496088 description "სამეცნიერო სტატია" @default.
- Q100496088 name "Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study" @default.
- Q100496088 name "Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study" @default.
- Q100496088 name "Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study" @default.
- Q100496088 type Item @default.
- Q100496088 label "Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study" @default.
- Q100496088 label "Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study" @default.
- Q100496088 label "Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study" @default.
- Q100496088 prefLabel "Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study" @default.
- Q100496088 prefLabel "Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study" @default.
- Q100496088 prefLabel "Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study" @default.
- Q100496088 P1433 Q100496088-AF03B858-03D8-4686-BCFE-9C12865CC9D5 @default.
- Q100496088 P1476 Q100496088-A042BAC2-481B-4BDF-9DE6-A94BB3565AAD @default.
- Q100496088 P2093 Q100496088-C2A7363D-33E2-4029-A480-BE35E0112BA1 @default.
- Q100496088 P2093 Q100496088-D460E11F-10F9-4C8C-923D-75FF271A0283 @default.
- Q100496088 P2093 Q100496088-D71A11BB-776A-4173-9D31-BF638C905F66 @default.
- Q100496088 P304 Q100496088-5D8BF8AB-4B1F-476A-97AB-49988F27994A @default.
- Q100496088 P31 Q100496088-FF95E6B7-D56B-4730-A7C9-FFBD50A14C19 @default.
- Q100496088 P356 Q100496088-9A31EC2A-0447-4A06-97D5-8C3EE69C2B03 @default.
- Q100496088 P50 Q100496088-F0819610-D8BB-4373-B75F-944ED5153324 @default.
- Q100496088 P577 Q100496088-A137EC9F-AA2B-4D29-89B5-B9E31A98DF72 @default.
- Q100496088 P698 Q100496088-FAE9C5E5-FBD4-4DA4-A8CD-8614E63F4091 @default.
- Q100496088 P921 Q100496088-BA350436-0B51-4C80-B81C-BC44E3CAB1BD @default.
- Q100496088 P356 03007995.2020.1834374 @default.
- Q100496088 P698 33030354 @default.
- Q100496088 P1433 Q5195063 @default.
- Q100496088 P1476 "Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study" @default.
- Q100496088 P2093 "Kentaro Taki" @default.
- Q100496088 P2093 "Momoha Koyanagi" @default.
- Q100496088 P2093 "Soshi Nagaoka" @default.
- Q100496088 P304 "1" @default.
- Q100496088 P31 Q13442814 @default.
- Q100496088 P356 "10.1080/03007995.2020.1834374" @default.
- Q100496088 P50 Q91730236 @default.
- Q100496088 P577 "2020-10-08T00:00:00Z" @default.
- Q100496088 P698 "33030354" @default.
- Q100496088 P921 Q417317 @default.